Mid American Wealth Advisory Group, Inc. Intellia Therapeutics, Inc. Transaction History
Mid American Wealth Advisory Group, Inc.
- $210 Billion
- Q2 2025
A detailed history of Mid American Wealth Advisory Group, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Mid American Wealth Advisory Group, Inc. holds 34 shares of NTLA stock, worth $698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34Holding current value
$698% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
333Shares Held
97.2MCall Options Held
1.66MPut Options Held
1.03M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$267 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$223 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$197 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.12MShares$84.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.04MShares$83 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.56B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...